Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$90,620,832
+$1,375,881 QoQ
Shares Held
578,234
-1.0% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#39
of 1,603 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Harding Loevner LP holds $340,761,986 across 4 Drug Manufacturers - General names. NVS ranks #2 (26.6% of the industry book) .
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $90,620,832 | 578,234 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $89,244,951 | 584,255 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $83,188,965 | 603,387 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $80,785,813 | 629,958 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $37,939,902 | 313,527 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||